127 related articles for article (PubMed ID: 3141342)
21. Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve-chequerboard method.
Drugeon HB; Caillon J; Juvin ME; Pirault JL
J Antimicrob Chemother; 1987 Feb; 19(2):197-203. PubMed ID: 3106301
[TBL] [Abstract][Full Text] [Related]
22. [The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Higurashi Y; Okuzumi K; Yoneyama A; Nakahara K
Jpn J Antibiot; 1997 Dec; 50(12):907-16. PubMed ID: 9545668
[TBL] [Abstract][Full Text] [Related]
23. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
Linda H; Patzer J
Med Dosw Mikrobiol; 1984; 36(4):223-9. PubMed ID: 6100122
[No Abstract] [Full Text] [Related]
24. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.
Weinstein RJ; Young LS; Hewitt WL
J Lab Clin Med; 1975 Nov; 86(5):853-62. PubMed ID: 810533
[TBL] [Abstract][Full Text] [Related]
25. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
26. [Evaluation of a E-test method to detect bactericidy of beta lactam-aminoglycoside associations against Pseudomonas aeruginosa isolates from cystic fibrosis].
Massoni-Cristante S; Loiez C; Adriensen B; Husson MO
Pathol Biol (Paris); 2003 Apr; 51(3):135-42. PubMed ID: 12781793
[TBL] [Abstract][Full Text] [Related]
27. Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model.
Chan E; Zhou S; Srikumar S; Duan W
Pharm Res; 2006 Apr; 23(4):729-41. PubMed ID: 16554956
[TBL] [Abstract][Full Text] [Related]
28. [In vitro combination effects of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa. In vitro synergistic activities].
Iyama Y; Sato K; Okachi R
Jpn J Antibiot; 1985 Apr; 38(4):1022-8. PubMed ID: 3928940
[TBL] [Abstract][Full Text] [Related]
29. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B
J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
[TBL] [Abstract][Full Text] [Related]
30. The patterns and transmissibility of antibiotic resistance among clinical strains of Pseudomonas aeruginosa.
Palillo ES; Salleh MA
Microbiol Immunol; 1992; 36(11):1195-200. PubMed ID: 1491621
[TBL] [Abstract][Full Text] [Related]
31. L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Valiant ME; Gilfillan EC; Gadebusch HH; Pelak BA
J Antibiot (Tokyo); 1989 May; 42(5):807-14. PubMed ID: 2498278
[TBL] [Abstract][Full Text] [Related]
32. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
Nazli E; Zer Y; Eksi F
J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
[TBL] [Abstract][Full Text] [Related]
33. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
34. Evaluating synergy between marbofloxacin and gentamicin in Pseudomonas aeruginosa strains isolated from dogs with otitis externa.
Jerzsele Á; Pásztiné-Gere E
Acta Microbiol Immunol Hung; 2015 Mar; 62(1):45-55. PubMed ID: 25823453
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo synergy of arachidonate-enriched serum with ceftazidime and amikacin on multidrug-resistant Pseudomonas aeruginosa.
Giamarellos-Bourboulis EJ; Plachouras D; Skiathitis S; Raftogiannis M; Dionyssiou-Asteriou A; Dontas I; Karayannacos PE; Giamarellou H
J Antimicrob Chemother; 2003 Feb; 51(2):423-6. PubMed ID: 12562715
[TBL] [Abstract][Full Text] [Related]
36. Optimization of Synergistic Combination Regimens against Carbapenem- and Aminoglycoside-Resistant Clinical Pseudomonas aeruginosa Isolates via Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling.
Yadav R; Bulitta JB; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821448
[TBL] [Abstract][Full Text] [Related]
37. Postantibiotic effect of a combination of antimicrobial agents on pseudomonas aeruginosa.
Sood P; Mandal A; Mishra B
Chemotherapy; 2000; 46(3):173-6. PubMed ID: 10765031
[TBL] [Abstract][Full Text] [Related]
38. Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
Yu PK; Edson RS; Washington JA; Hermans PE
Antimicrob Agents Chemother; 1983 Jan; 23(1):179-81. PubMed ID: 6219619
[TBL] [Abstract][Full Text] [Related]
39. Preclinical comparative evaluation of aminoglycosides.
Abbate GF; Alagia I; Giaquinto E; Giordano B; Leonessa V; Altucci P
Chemioterapia; 1984 Dec; 3(6):378-84. PubMed ID: 6529780
[TBL] [Abstract][Full Text] [Related]
40. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M
Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
